The trajectories of sleep disturbances in Rett syndrome

Journal of Sleep Research

Volumn 24, Issue 2, 2015, Pages 223-233

  Wong, Kingsley ^a   Leonard, Helen ^a   Jacoby, Peter ^a   Ellaway, Carolyn ^b   Downs, Jenny ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Longitudinal study; MECP2

Indexed keywords

ALIMEMAZINE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CHLORAL HYDRATE; CLONIDINE; FLUOXETINE; HALOPERIDOL; HYPNOTIC AGENT; MELATONIN; MIRTAZAPINE; OLANZAPINE; PROMETHAZINE; RISPERIDONE; METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; CHILD; FEMALE; GENE MUTATION; GROWTH; HUMAN; LAUGHTER; MAJOR CLINICAL STUDY; NIGHT; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; RISK REDUCTION; SLEEP DISORDER; WAKEFULNESS; AGE DISTRIBUTION; AUSTRALIA; COMPLICATION; FACTUAL DATABASE; GENETICS; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PREVALENCE; SLEEP WAKE DISORDERS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; LAUGHTER; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PHENOTYPE; PREVALENCE; RETT SYNDROME; SLEEP WAKE DISORDERS; WAKEFULNESS;

EID: 84923841774     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12240     Document Type: Article

References (37)

1. Ager, S., Fyfe, S., Christodoulou, J., Jacoby, P., Schmitt, L. and Leonard, H. Predictors of scoliosis in Rett syndrome. J. Child Neurol., 2006, 21: 809-813.
2. Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U. and Zoghbi, H. Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 1999, 23: 185-188.
3. Andruff, H., Carraro, N., Thompson, A. and Gaudreau, P. Latent class growth modelling: a tutorial. Tutorials Quant. Meth. Psych., 2009, 5: 11-24.
4. Bao, X., Downs, J., Wong, K., Williams, S. and Leonard, H. Using a large international sample to investigate epilepsy in Rett syndrome. Dev. Med. Child Neurol., 2013, 55: 553-558.
5. Bebbington, A., Anderson, A., Ravine, D. et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology, 2008, 70: 868-875.
6. Cuddapah, V. A., Pillai, R. B., Shekar, K. V. et al. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J. Med. Genet., 2014, 51: 152-158.
7. Didden, R., Curfs, L. M., Van Driel, S. and De Moor, J. M. Sleep problems in children and young adults with developmental disabilities: home-based functional assessment and treatment. J. Behav. Ther. Exp. Psychiatry, 2002, 33: 49-58.
8. Dorris, L., Scott, N., Zuberi, S., Gibson, N. and Espie, C. Sleep problems in children with neurological disorders. Dev. Neurorehabil., 2008, 11: 95-114.
9. Downs, J., Bebbington, A., Woodhead, H. et al. Early determinants of fractures in Rett syndrome. Pediatrics, 2008, 121: 540-546.
10. Ellaway, C., Peat, J., Leonard, H. and Christodoulou, J. Sleep dysfunction in Rett syndrome: lack of age related decrease in sleep duration. Brain Dev., 2001, 23(Suppl. 1): S101-S103.
11. Fehr, S., Bebbington, A., Ellaway, C., Rowe, P., Leonard, H. and Downs, J. Altered attainment of developmental milestones influences the age of diagnosis of Rett syndrome. J. Child Neurol., 2011, 26: 980-987.
12. Hagberg, B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatr., 1995, 84: 971-976.
13. Hagberg, B. Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 2002, 8: 61-65.
14. Hagberg, B. Rett syndrome: long-term clinical follow-up experiences over four decades. J. Child Neurol., 2005, 20: 722-727.
15. Hagberg, B., Hanefeld, F., Percy, A. and Skjeldal, O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur. J. Paediatr. Neurol., 2002, 6: 293-297.
16. Hollway, J. A. and Aman, M. G. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res. Dev. Disabil., 2011, 32: 939-962.
17. Jones, B. L. and Nagin, D. S. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol. Method Res., 2007, 35: 542-571.
18. Jones, B. L., Nagin, D. S. and Roeder, K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol. Method Res., 2001, 29: 374-393.
19. Lee, J., Leonard, H., Piek, J. and Downs, J. Early development and regression in Rett syndrome. Clin. Genet., 2013, 84: 572-576.
20. Leonard, H., Downs, J., Jian, L. et al. Valproate and risk of fracture in Rett syndrome. Arch. Dis. Child., 2010, 95: 444-448.
21. Mcarthur, A. J. and Budden, S. S. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev. Med. Child Neurol., 1998, 40: 186-192.
22. Mcdougall, A., Kerr, A. M. and Espie, C. A. Sleep disturbance in children with Rett syndrome: a qualitative investigation of the parental experience. J. Appl. Res. Intellect. Disabil., 2005, 18: 201-215.
23. Mount, R. H., Charman, T., Hastings, R. P., Reilly, S. and Cass, H. The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J. Child Psychol. Psychiatry, 2002, 43: 1099-1110.
24. Nagin, D. S. Group-Based Modeling of Development. Harvard University Press, Cambridge, MA, 2005.
25. Naidu, S., Murphy, M., Moser, H. W. and Rett, A. Rett syndrome-natural history in 70 cases. Am. J. Med. Genet. Suppl., 1986, 1: 61-72.
26. Neul, J. L., Kaufmann, W. E., Glaze, D. G. et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann. Neurol., 2010, 68: 944-950.
27. Nomura, Y. Early behavior characteristics and sleep disturbance in Rett syndrome. Brain Dev., 2005, 27(Suppl. 1): S35-S42.
28. Nomura, Y. and Segawa, M. Clinical features of the early stage of the Rett syndrome. Brain Dev., 1990, 12: 16-19.
29. Nomura, Y., Segawa, M. and Higurashi, M. Rett syndrome-an early catecholamine and indolamine deficient disorder? Brain Dev., 1985, 7: 334-341.
30. Piazza, C. C., Fisher, W., Kiesewetter, K., Bowman, L. and Moser, H. Aberrant sleep patterns in chuldren with rett syndrome. Brain Dev., 1990, 12: 488-493.
31. Piazza, C. C., Fisher, W. and Moser, H. Behavioral treatment of sleep dysfunction in patients with the Rett syndrome. Brain Dev., 1991, 13: 232-237.
32. SAS Institute Inc. SAS (r) Proprietary Software 9.3. SAS Institute Inc., Cary, NC, 2002-2010.
33. StataCorp. Stata Statistical Software: Release 12. StataCorp LP, College Station, TX, 2011.
34. Wiggs, L. and Stores, G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev. Med. Child Neurol., 2004, 46: 372-380.
35. Witt-Engerström, I. Evolution of clinical signs. In: B. Hagberg (Ed) Rett Syndrome-Clinical and Biological Aspects. Mac Keith Press, London, 1993, 26-39.
36. Young, D., Nagarajan, L., De Klerk, N., Jacoby, P., Ellaway, C. and Leonard, H. Sleep problems in Rett syndrome. Brain Dev., 2007, 29: 609-616.
37. Zeger, S. L. and Liang, K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 1986, 42: 121-130.